Homayoun Hashemi, MD
Vascular Surgery · Fairfax, VANPI 1356310742
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,886 and has fallen 71.5% since, to $537 in 2025. That places this record below the midpoint for vascular surgery clinicians in VA, where the typical reported total is $4,916.
Across 65 payments — averaging $71.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$1K
- Endologix LLC$713
- Lemaitre Vascular, Inc.$610
- Silk Road Medical, Inc.$466
- Johnson & Johnson$354
- Abbott$321
- plus $1K from 12 others
Across 15 payments — averaging $6939.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endologix LLC$104K
What the payments were for
- Speaking & faculty fees$1714%
- Food & beverage$4,45996%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 10 | $1,048 |
| Endologix LLC | 10 | $713 |
| Lemaitre Vascular, Inc. | 7 | $610 |
| Silk Road Medical, Inc. | 7 | $466 |
| Johnson & Johnson | 3 | $354 |
| Abbott | 2 | $321 |
| Edwards Lifesciences | 1 | $150 |
| Biocompatibles, Inc. | 1 | $145 |
| Cardinal Health 200 LLC | 4 | $134 |
| Medtronic | 3 | $127 |
| Smith+Nephew | 1 | $122 |
| Cook Medical LLC | 6 | $108 |
| Tactile Systems Technology Inc | 1 | $98 |
| Terumo Medical Corporation | 3 | $82 |
| Shockwave Medical, Inc | 3 | $75 |
| Philips North America LLC | 1 | $32 |
| Cardiovascular Systems Inc. | 1 | $25 |
| Cordis US CORP. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXCLUDER AAA Endoprosthesis$372
- XARELTO$261
- ENROUTE Transcarotid Neuroprotection System$256
- ENHANCE Transcarotid Peripheral Access Kit$256
- XENOSURE BIOLOGIC PATCH$214
- VIABAHN Endoprosthesis$191
- Perclose ProGlide suture mediated closure system$171
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$166
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$150
- XACT$150
- VARITHENA$145
- ENROUTE .014 Guidewire$139
- ENROUTE Transcarotid Stent$139
- TIGRIS Stent$128
- Santyl$122
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$119
- ENROUTE Transcarotid Stent System$117
- ENROUTE 0.014 Guidewire$117
- AFX$107
- Ovation$107
How this compares
$4,629 in reported general payments places this provider in the 45th percentile of 143 vascular surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $16,627 |
| XareltoRivaroxaban | 12 | $6,677 |
| LumiganBimatoprost | 13 | $3,185 |
| ClopidogrelClopidogrel Bisulfate | 65 | $967 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 207 | $559 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 166 | $516 |
| Atorvastatin Calcium | 27 | $195 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $354 | $6,67712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 143 vascular surgery providers in Virginia.
Other vascular surgery in Fairfax
- Joseph BabrowiczFairfax$202K
- Jean PannetonVirginia Beach$1.3M
- John DeitrickRichmond$684K
- Rasesh ShahChesapeake$465K
- David DexterNorfolk$404K
- Samuel SteermanVirginia Beach$252K
- Joshua AdamsRoanoke$138K
- Richard NevilleFalls Church$114K
- Anthony ComerotaFalls Church$107K
- Animesh RathoreNorfolk$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.